key: cord-0284226-kugassn3
authors: Skirrow, C.; Meszaros, M.; Meepegama, U.; Lenain, R.; Papp, K. V.; Weston, J.; Fristed, E.
title: Validation of a novel fully automated story recall task for repeated remote high-frequency administration
date: 2021-10-17
journal: nan
DOI: 10.1101/2021.10.12.21264879
sha: 9dfa9a7ec25682426cd2a3c8bde24ed5ea4f93f3
doc_id: 284226
cord_uid: kugassn3

INTRODUCTION: Longitudinal data is key to identifying cognitive decline and treatment response in Alzheimer's disease (AD). METHODS: The Automatic Story Recall Task (ASRT) is a novel, fully automated test that can be self-administered remotely. In this longitudinal case-control observational study, 151 participants (mean age: 69.99 (range 54-82), 73 mild cognitive impairment/mild AD and 78 cognitively unimpaired) completed parallel ASRT assessments on their smart devices over 7-8 days. Responses were automatically transcribed and scored using text similarity metrics. RESULTS: Participants reported good task usability. Adherence to optional daily assessment was moderate. Parallel forms correlation coefficients between ASRTs were moderate-high. ASRTs correlated moderately with established tests of episodic memory and global cognitive function. Poorer performance was observed in participants with MCI/Mild AD. DISCUSSION: Unsupervised ASRT assessment is feasible in older and cognitively impaired people. This automated task shows good parallel forms reliability and convergent validity with established cognitive tests.

Although remote digital assessments are not new, the SARS-CoV-2 global pandemic accelerated the need to adopt remote or hybrid clinical assessment or research methods [19, 20] . Alongside advances in technology and connectivity, this has led to a growing appetite for using personal digital devices to collect clinically informative data. Beyond this, digital health technologies can enhance inclusivity, improving access for people who experience mobility problems or those with financial, geographical or time restrictions [21] .

The current study describes the Automatic Story Recall Task (ASRT), a remote, self-administered and automatically scored test developed for repeated cognitive assessment, opening up opportunities for much more nuanced longitudinal data analysis. We examine test characteristics in participants who are cognitively unimpaired, have mild cognitive impairment (MCI) or have mild AD, assessed repeatedly over one week. We examine: (1) acceptability of remote ASRT assessment; (2) adherence to daily remote ASRT assessments; (3) parallel forms reliability; (4) convergent validity with established episodic memory and general cognition measures; (5) task performance characteristics; and (6) the impact of daily internal state factors.

Participants were recruited from November 2020-August 2021 from three sites in the UK (London/Guildford, Plymouth, and Birmingham), and the USA (Santa Ana, California). Subjects were enrolled if they were cognitively unimpaired (CU) or diagnosed with MCI in the prior 5 years. In the UK study, participants diagnosed with mild AD in the last 5 years were also included. MCI due to AD and mild AD diagnoses were made following National Institute of Aging-Alzheimer's Association core clinical criteria [22] . Subjects were approached if they had undergone a prior Amyloid beta (A ) PET scan or CSF test (confirmed A -within 30 months or A + within 60 months). Eligibility was established by screening via video call using a secure Zoom link or in-clinic assessment, during which the Mini-Mental State Exam (MMSE) [23] was administered.

Inclusion criteria comprised age 50-85; MMSE score of 23-30 for participants with MCI or Mild AD, 26-30 for CU; cognitively unimpaired or clinical diagnosis of MCI/mild AD made in previous 5 years; English as a first language; availability of an informant for clinical interview (caregiver or close associate); access and ability to use a smartphone running an operation system of Android 7 or above, or iOS 11 or above.

Exclusion criteria: current diagnosis of general anxiety disorder (GAD); recent (6-month) history of unstable psychiatric illness; history of stroke within the past 2 years or a documented history of transient ischaemic attack or unexplained loss of consciousness in the last 12 months. Participants treated with medications for symptoms related to AD were required to be taking a stable dose at least 8 weeks. Participants with a current diagnosis of major depressive disorder (MDD) (UK study) or those with current or a 2-year history of MDD (US study) were excluded. [24] evaluates free recall of a story according to 25 pre-defined information units (IUs: a metric quantifying the amount of information recalled, with each unit capturing the semantic essence of a part of the story [25] ), immediately after presentation, and after a 30-minute delay. Paraphrased answers were accepted and scoring was completed manually using a standard scoring template.

Cognitive tests incorporated in the Preclinical Alzheimer's Cognitive Composite with semantic processing (PACC5) were administered. Tests were manually scored and a mean z-score was calculated as described in prior research [11] . The Clinical Dementia Rating scale (CDR) [26] , a semi-structured interview assessing severity of cognitive symptoms of dementia, was completed with the participant and their caregiver and scored based on the CDR Sum of Boxes (CDR-SOB) scales. In the US study, where participants had completed subtests of the PACC5 or CDR assessments within one month prior to the study visit, tests were not re-administered but the recent historical test results were used.

During clinical assessments, participants were supported with installing the Novoic mobile application ('the app') on their own smartphone device and were shown how to use it.

3 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Participants were encouraged to complete optional unsupervised self-assessments (<30 mins) on the app daily for up to eight days following the study visit.

Remote assessments included the Automatic Story Recall Tasks (ASRTs), which are story recall tasks constructed to elicit naturalistic speech within a closed domain. ASRTs are presented at a steady reading rate (approximately 140 words per minute) by a British male speaker. Parallel stimuli available include 18 short stories (mean of 30 IUs and 119 words per story) and 18 long stories (mean of 60 IUs and 224 words per story). Task characteristics are presented in supplementary table S1, showing that stories incorporate a range of themes and are balanced for key linguistic and discourse metrics.

ASRTs were administered daily, in threes (triplets) and at the beginning of each remote assessment. Participants were asked to listen to the stories carefully. After each story was presented they were asked to immediately retell the story in as much detail as they could remember. Recall of the same stories, in the same order, was tested again after a delay (either after completion of all immediate recalls or after a distractor task). Task responses were automatically uploaded to a secure server.

Due to participant feedback regarding high burden, the assessment schedule was changed partway through the study. The new schedule favoured the use of shorter stories and reduced the number of additional assessments which followed ASRTs (not reported here). Simultaneously, the number of days of remote assessment was increased from seven to eight days to spread out assessments. Details are provided in supplementary table S2.

Daily state effects were assessed after completion of ASRTs via a four-item self-report questionnaire asking how they were feeling that day (current mood, sleep, mind-wandering and effort). App and task usability was assessed via a self-report questionnaire at the end of the assessment on day 2 (initial assessment schedule) or day 5 (revised assessment schedule). Participants reported technical difficulties experienced during assessments, whether technical difficulties prevented them from completing the assessments, how easy and how interesting it was to complete the assessments. Questionnaires are shown in supplementary tables S3 and S4.

Stories were transcribed using an out-of-the-box automatic speech recognition (ASR) system, followed by automated textual analysis completed using a generalized matching score (referred to here for brevity as "G-match"), computed in Python as the weighted sum of the cosine similarity between the embeddings of the source documentation (original ASRT text) and the transcribed retellings. G-match provides an index of the proportional recall for each story, with potential scores ranging from 0 to 1 (hypothetically perfect performance). Mean G-match per triplet was also computed.

All further analysis was completed in R v.4.0. Data were assessed for normality, followed by parametric and non-parametric analyses, as appropriate. Since a large proportion of participants only completed seven days of remote assessments, analyses were limited to assessments on days 1-7.

4 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Adherence to the remote testing regimen was defined as engaging with at least one ASRT story per day. Overall adherence patterns were examined with two logistic regression models, predicting adherence at immediate and delayed recall, in relation to participant group, demographic factors, assessment day and schedule. Participants were included as random effects. Demographic factors (sex, age, years in education), remote assessment days (1−7), research schedule (schedule 1 or schedule 2) and participant group (CU or MCI/mild AD) were included as fixed factors.

Parallel forms reliability of ASRTs was examined with pairwise correlational analysis. Only ASRTs administered across both schedules were analysed, to maintain comparable sample sizes across comparisons and allow for testing within MCI/mild AD and CU subgroups. Convergent validity of these same ASRT stories was examined in relation to the LMT, PACC5 and CDR-SOB. Analyses were repeated with the mean G-score per triplet. Due to variation in the distributions of tests, and to improve consistency and comparability of reporting, Spearman's rank correlation coefficients are reported.

Task performance differences between groups, task administration variations and over time were modeled using longitudinal linear mixed effects models. This included G-match for individual ASRTs as the response variable, and fixed effects of participant group, remote assessment days (1-7), order (1st, 2nd or 3rd ASRT presented), long or short stories and immediate or delayed recall. Demographic covariates (age, sex, education) were included as additional fixed effects. A random effect of participant with random slope and intercept was specified.

Analyses were repeated with the mean G-match per triplet, with equivalent random and fixed effects specifications, excepting story order which was not included. Covariation of mean ASRT task performance across triplets with self-reported daily state was then examined, by additionally incorporating fixed effects of self-reported mood, sleep, effort and mind-wandering, into the above model. Assumptions of regression models were investigated by examining the distribution and patterns of residuals versus fitted values.

Two hundred participants, 67 from the US study and 133 from the UK study, were recruited. One hundred and fifty-one participants (75.5%) completed at least one remote ASRT. Older participants (r=-0.15, p= 0.03), those with higher MMSE scores (r=-0.26, p< 0.001) and those with MCI/mild AD (73/106 MCI (69%) and 78/94 CU (83%); χ²=5.36 (DF=1), p=0.02) were less likely to complete any remote assessments. There were no differences in sex ratio (χ²=0.41 (DF=1), p=0.52), or years in education (r=-0.01 p-value = 0.87) between participants who contributed at least one remote assessment and those who did not.

Demographic information for the 151 participants providing remote data are presented in table 1. In this subsample, MCI and CU groups did not differ with respect to key demographic factors (age, years in education, sex) or amyloid status. Proportionally more participants with MCI were recruited and completed remote assessments in the US study. 5 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Usability questionnaires were completed by 96 participants (n=52 CU, n=44 MCI/mild AD), with results presented in figure 1 . Participants reported few technical difficulties and most reported that technical difficulties had not prevented them from completing the assessments, with no group differences (χ²=3.32 (DF=1), p=0.07 and χ²=0.98 (DF=1), p=0.32, respectively). Participants overwhelmingly responded that the app was easy to use, and that the task was reasonably interesting, again with no group differences (r=-0.08, p=0.47 and r=-0.04, p=0.70, respectively).

6 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

Participants with MCI/mild AD completed fewer remote assessments than CU participants (adherence for immediate recall: 66% versus 78%; delayed recall: 63% versus 77%; figure  2 ). Group differences in adherence were confirmed by mixed logistic regression analyses (immediate recall, estimate=-1.00, p=0.01; delayed recall estimate =-0.84, p=0.02). Adherence did not change over time (immediate recall estimate=-0.04, p=0.30; delayed recall estimate=-0.07, p=0.13), but lower adherence to delayed recall was seen for the revised test schedule (fixed effects estimate=-0.86, p=0.03). Adherence was not associated with sex and education (all p>0.2), but younger participants completed more assessments 7 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Figure 2: Adherence and task performance heatmap for G-match in immediate recall trials. G-match is an automated measure of recall performance (see methods). Results plotted across individual days of remote assessment for n=151 participants who completed at least one assessment. Each participant is represented by a row, missing data are shown in grey, and mean G-match across ASRT triplets is shown in colour (red=low recall; yellow=high recall). Figure SF1-4) . Task performance characteristics separated by group and immediate and delayed recall, are provided in supplementary tables S5-S7. Longer stories elicited a greater number of spoken words, but G-match for longer stories was typically lower, indicating that high levels of recall similarity to original text are harder to achieve with longer source texts. Figure 3A provides an overview of recall for individual ASRTs, showing variability between parallel ASRTs and long and short stories. 8 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 3.6 Convergent validity ASRT task performance correlated moderately with other cognitive measures (LMT, CDR-SOB and PACC5) in the full sample across both immediate and delayed recalls. Convergent validity for immediate recall ASRTs is shown in figure 4 . Delayed recall, and correlation coefficients separated by participant group are provided in supplementary Figures SF 5-9 ). Correlation coefficients remained in the moderate range after restricting analyses to participants with MCI/mild AD but were typically lower in CU participants.

10 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint Figure 4 : Matrix of pairwise correlation coefficients of test-retest reliability for G-match, an automated measure of recall performance, of individual ASRT stories. Convergent validity is examined through correlations between ASRT stories with other cognitive test scores (LMIR, CDR-SOB, PACC5) obtained during clinical assessments. To maintain consistent reporting, the sign of the correlation for the CDR-SOB is reversed in the above figure, meaning that for all tests higher scores denote better cognitive test performance. Pairwise correlation coefficients for ASRTs reflect parallel task performance metrics for between n=80-116 participants, and with other cognitive tests for n=89-149, depending on adherence patterns. 3.7 Task performance Longitudinal mixed models of task performance by study day are presented in table 2, revealing similar results for individual ASRTs and triplets. Task performance modestly improved across the week. There was an effect of group, with lower scores in the MCI/mild 11 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint AD group. G-match was higher for immediate recall, shorter stories, and more elevated for the latter ASRTs administered within each triplet. Demographic measures were not associated with task performance. Results are displayed in figure 3B , showing within and between-subject variability.

After incorporating self-report assessments into the mixed model predicting average G-match for triplets, models revealed a significant effect of mood (estimate=0.006 (SE=0.001), p<0.001) and mind-wandering (estimate=-0.009 (SE=0.001), p<0.001) on daily ASRT performance, with better daily mood and lower mind-wandering associated with better task daily performance. 

Older participants, with and without cognitive impairment, engaged in optional daily remote unsupervised speech assessments with moderate levels of adherence. Task performance on the ASRT differed between clinical groups. Subjects experienced few technical problems 12 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021. 10.12.21264879 doi: medRxiv preprint and reported that the tests were easy to use and reasonably interesting. Results show that remote automatic test administration and auto-scoring of test performance is feasible and can provide sensitive cognitive measurement in key populations.

ASRT stimuli were carefully designed and balanced, which in turn is reflected in good parallel forms reliability, with moderate to high correlations between ASRT variants. ASRT tests also correlated moderately with a well established test of verbal episodic memory and tests global cognition, indicating acceptable convergent validity, and with results comparable to, or better than, other studies of computerised or unsupervised remote assessments [27] [28] [29] . The current study also examined correlation coefficients within the two clinical groups. Convergent validity was typically lower in CU participants, which can be linked to ceiling or floor-level performance on certain traditional cognitive tests in healthy individuals.

The lack of decline in adherence over time indicates that testing over a weeklong period does not produce testing fatigue effects sufficient to have an impact on rates of daily participation. Nor does continued participation adversely affect test scores, since these improved modestly during the week, indicating that increased familiarity with the app, testing procedure and/or test structure resulted in a subtle improvement over time.

The current study shows within-subject variation in task performance, in part reflecting measurable effects of state factors on cognitive performance, in particular daily mood and effort. Task performance differences also reflect aspects of study design, with stories administered later in the triplets delivering more comprehensive recall than those administered earlier, and longer stories producing less comprehensive recall than shorter stories.

A higher proportion of older and more cognitively impaired participants did not engage in remote assessment. This may reflect that remote assessments themselves were optional. Although most participants were able to engage with remote assessment, the testing schedule was altered in the middle of the study to reduce participant burden, thereby limiting the amount of data available for certain ASRT parallel test variants. Overall these findings indicate that brief remote assessments are likely to be more acceptable in this population. Assessment under supervision, either in clinic or during a telemedicine visit, could be more appropriate for more impaired subjects.

The design of the study makes it difficult to differentiate between the effects of individual stories themselves (i.e. which ASRT story was used) and effects of study design, such as test order or day of assessment. Future studies may benefit from adopting a randomised design, with ASRTs randomly selected and allocated to different testing instances, to derive test performance metrics independent of these additional confounders. For longitudinal studies, either short or long stories should be adopted to improve consistency of test scores over time and help to better characterise cognitive change.

The recent FDA approval for the first disease modifying treatment for people at risk of developing AD highlights the importance of adequate screening and early detection, as well 13 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint as the importance of monitoring treatment response. Briefer, convenient and lower-burden daily assessments may provide more reliable data to evaluate disease progression or treatment response than one-off lengthy assessments [9] . The current study shows that brief, remotely administered and automatically scored ASRTs are sensitive to early cognitive impairments commonly identified through more extensive clinical assessment. The tests show good properties for repeated administration, and convergent validity with established tests of episodic memory and global cognitive function.

Speech responses are a common component of cognitive tests, however data generated in these tests, including those reported in this study, often relate to simple pass/fail characteristics of response accuracy. New metrics using audio-and text-based AI models to target other changes measurable in speech data (acoustic [30, 31] , semantic [32] [33] [34] [35] , linguistic [31] ) in early-stage Alzheimer's disease could further leverage the information content of ASRTs, developing a new class of powerful, fully automated speech biomarkers.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 17, 2021. ; https://doi.org/10.1101/2021.10.12.21264879 doi: medRxiv preprint

FDA Grants Accelerated Approval for Alzheimer's Drug 2021

Regulatory innovation and drug development for early-stage Alzheimer's disease

Guideline on the clinical investigation of medicines for the treatment of Alzheimer's disease

Self-reported sleep duration and cognitive performance in older adults: a systematic review and meta-analysis

The effects of acute exercise on cognitive performance: a meta-analysis

The psychological, neurochemical and functional neuroanatomical mediators of the effects of positive and negative mood on executive functions

I'm going to fail! Acute cognitive performance anxiety increases threat-interference and impairs WM performance

Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study

Feasibility and validity of mobile cognitive testing in the investigation of age-related cognitive decline

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5

Determining clinically meaningful decline in preclinical Alzheimer disease

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score

Measuring longitudinal cognition: Individual tests versus composites

Diagnostic accuracy of the UDS 3.0 neuropsychological battery in a cohort with Alzheimer's disease in Colombia

Mini Mental State Examination and Logical Memory scores for entry into Alzheimer's disease trials

Consortium for the Early Identification of Alzheimer's disease-Quebec. Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis

Fully Automated Neuropsychological Assessment for Detecting Mild Cognitive Impairment

Developing digital tools for remote clinical research: how to evaluate the validity and practicality of active assessments in field settings

Viewpoint: Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer's Disease Center Facing the Covid-19 Crisis

Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation. Virtual clinical trials: challenges and opportunities: proceedings of a workshop

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Mini-mental state" A practical method for grading the cognitive state of patients for the clinician

Wechsler Memory Scale-Revised

Reliability and concurrent validity of the information unit scoring metric for the story retelling procedure

The Clinical Dementia Rating (CDR): current version and scoring rules

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

Alzheimer's & Dementia: Diagnosis

Reliability and Validity of a Home-Based Self-Administered Computerized Test of Learning and Memory Using Speech Recognition

Validation of computerized episodic memory measures in a diverse clinical sample referred for neuropsychological assessment

Ten years of research on automatic voice and speech analysis of people with alzheimer's disease and mild cognitive impairment: A systematic review article

Spoken language derived measures for detecting mild cognitive impairment

Getting the hang of it: preferential gist over verbatim story recall and the roles of attentional capacity and the episodic buffer in Alzheimer disease

Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease

Deficits in narrative discourse elicited by visual stimuli are already present in patients with mild cognitive impairment

Serial position effects in the Logical Memory Test: Loss of primacy predicts amyloid positivity